封面
市场调查报告书
商品编码
1410774

人工硬脑膜市场:按细分市场划分的规模、份额、法律法规、报销、程序、到 2033 年的预测

Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

人工硬脑膜是修復硬脑膜时用作片材或材质的补片。闭合或修復硬脑膜对于防止脑脊髓液(CSF)渗漏至关重要。

生物人工硬脑膜具有进行血管和上皮融合的能力,有助于其与天然硬脑膜整合。这种类型的替代硬脑膜的加工方式是去除所有细胞和抗原,并且不存在疾病传播的可能性。由于这些原因,神经血管外科医生更喜欢使用生物硬脑膜而不是合成硬脑膜。生物硬脑膜替代物具有良好的拉伸强度,使得补片植入后稳定。

该报告深入探讨了全球人造硬脑膜市场,包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。

目录

人工硬脑膜目前市场及竞争状况

  • 洞察关键产业趋势
  • 2015年至2033年人工硬脑膜各细分市场的市场总收入及市场前景
  • 有关数量、平均售价和市场价值的详细数据

全球、区域和国家见解

  • 人工硬脑膜市场的SWOT分析
  • 人工硬脑膜市场的竞争动态洞察与趋势
  • 按国家/地区划分的医疗保健系统概览
  • 各国报销政策
  • 各国医疗技术法规现状

Abstract

Dura Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Dura Substitutes market for the year 2020 and beyond. Dura Substitutes are patches which are used as sheet or material in repairing the dura mater. Closure or repair of dura mater is essential to prevent a Cerebrospinal Fluid (CSF) Leak.

The model considers two types of dura substitutes, biological and synthetic. Biological dura substitutes have the ability to undergo vascular and epithelial fusion which helps them to integrate with the native dura mater. This type of substitute is processed so that all cells and antigens are removed and chances of disease transmission is nil. For this reason, neurovascular surgeons prefer using biological dura substitutes over synthetic dura substitutes. The latter have good tensile strength which provides stability to the patch after implantation.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Dura Substitutes and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Dura Substitutes market revenue by segment and market outlooks from 2015-2033.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Dura Substitutes market.
  • Competitive dynamics insights and trends provided for Dura Substitutes market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Integra LifeSciences Corp, B. Braun Melsungen AG, Medtronic Plc, DePuy Synthes Inc, Regenity Biosciences, Baxter International Inc and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Dura Substitutes marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Dura Substitutes market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Dura Substitutes market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Dura Substitutes market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Dura Substitutes market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable